Holen Sie sich die Stockscreener-App
75.07
0.50%
0.37
Schlusskurs vom Vortag:
$74.70
Offen:
$75.68
24-Stunden-Volumen:
532.85K
Relative Volume:
0.83
Marktkapitalisierung:
$4.14B
Einnahmen:
$1.43B
Nettoeinkommen (Verlust:
$107.13M
KGV:
38.75
EPS:
1.9372
Netto-Cashflow:
$161.04M
1W Leistung:
-2.04%
1M Leistung:
-8.90%
6M Leistung:
+17.68%
1J Leistung:
+46.54%
1-Tages-Spanne:
$74.64
$76.77
1-Wochen-Bereich:
$74.47
$77.66
52-Wochen-Spanne:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
75.07 | 4.22B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LIVN6033156 Bond Profile: Coupon and Redemption - TradingView
Operating Leverage and Product Innovation Drive LivaNova’s(LIVN) Sustained Profit Outlook - Yahoo Finance
LivaNova PLC (LIVN) Stock Forecasts - Yahoo Finance
Press Release: LivaNova to Announce Third-Quarter 2026 Results - moomoo.com
LivaNova to Announce Third-Quarter 2026 Results - Business Wire
LivaNova stock stays at USD 3.50 as 52-week range widens - AD HOC NEWS
(LIVN) Volatility Zones as Tactical Triggers - Stock Traders Daily
LivaNova PLC (LIVN) Stock Analysis: A Healthcare Innovator with a 13.98% Upside Potential - DirectorsTalk Interviews
LivaNova stock holds steady as investors focus on recent earnings and pipeline - AD HOC NEWS
LivaNova (NASDAQ: LIVN) Grants 6,291 Derivative Securities to Chief Legal Officer Liddy Anne M. - Kalkine Media
Chief legal officer at LivaNova (LIVN) awarded 6,291 stock units vesting through 2029 - Stock Titan
LivaNova Director Francesco Bianchi Disposes 3,500 Shares at $78.01 Each (NASDAQ: LIVN) - Kalkine Media
LivaNova Director Trades $273K In Company Stock - Benzinga
LivaNova at Morgan Stanley conference: growth plan leans on core units By Investing.com - Investing.com South Africa
Director at LivaNova (LIVN) sells 3,500 shares in open-market trade - Stock Titan
LivaNova at Morgan Stanley conference: growth plan leans on core units - Investing.com India
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova Director Sells 1,650 Shares for $131,500 - The Motley Fool
LivaNova (NASDAQ: LIVN) officer plans 3,500-share sale from 2026 stock award vesting - Stock Titan
LivaNova (LIVN) Falls 1.64% to $79.38, Hovering at the Middle of Its Trading RangeSwing Entry Signals - siam.in
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setup - ChartMill
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - Stock Titan
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - Stock Titan
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - finance.yahoo.com
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - ad-hoc-news.de
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - Stock Titan
LivaNova PLC (LIVN) director sells 1,650 shares - Stock Titan
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - ad-hoc-news.de
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - sahmcapital.com
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move - vinanet.vn
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move: Shares Finish 0.61% Down in the Available RecordRevenue Growth Report - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionEarnings Manipulation Risk - vinanet.vn
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) Q2 2026 Earnings Call Transcript - AOL.com
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.26%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):